The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for ...
Pfizer had shelved the drug after it appeared that AstraZeneca would beat it to market with a competing drug. But mirdametinib still held value to the NF1 community, so the Children’s Tumor ...
But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...
Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback